ABBV receives CRL for ABBV-951 NDA for the treatment of motor fluctuations in adults with advanced Parkinson's disease.$艾伯维公司(ABBV)$ cns
发布于: | Android | 转发:0 | 回复:1 | 喜欢:0 |
ABBV receives CRL for ABBV-951 NDA for the treatment of motor fluctuations in adults with advanced Parkinson's disease.$艾伯维公司(ABBV)$ cns
第二次收到了CRL,皮下注射加个遥控器一样的pump还是天坑的神经系统类适应症 不和CMO工厂把这种药械结合的产品cmc过程完善提供准资料就是这个结果,坐等第三次重大变更